Latest News about why it's moving
Recent news which mentions why it's moving
From Benzinga
From Benzinga
What's Going On With Upstart (UPST) Stock?
August 12, 2024
From Benzinga
From Benzinga
What's Going On With Workhorse Group Shares Monday?
August 12, 2024
From Benzinga
Why Interactive Strength (TRNR) Stock Is Up Over 70%
August 12, 2024
From Benzinga
What's Going On With Rumble Stock Monday?
August 12, 2024
From Benzinga
What's Going On With Nikola Stock Today?
August 12, 2024
From Benzinga
Pain Management-Focused Pacira BioSciences Loses Patent Fight For Key Drug, JP Morgan Analyst Downgrades On Unclear Path
August 12, 2024
From Benzinga
New Hospital Operator On The Block Ardent Health Garners Interest As Analysts Initiate With Bullish View
August 12, 2024
From Benzinga
What's Going On With Cisco Stock?
August 12, 2024
From Benzinga
Coherent's AI Optical Transceiver And CEOs Turnaround Push Drive Growth: BofA Analyst
August 12, 2024
From Benzinga
What's Going On With SoundHound AI Stock Today?
August 12, 2024
From Benzinga
What's Going On With Hut 8 Stock Monday?
August 12, 2024
From Benzinga
From Benzinga
What's Going On With Alibaba Stock?
August 12, 2024
From Benzinga
What's Going On With Advanced Micro Devices Shares Monday?
August 12, 2024
From Benzinga
What's Going On With Nvidia Stock On Monday?
August 12, 2024
From Benzinga
From Benzinga
Why JetBlue Airways Stock Is Falling Sharply
August 12, 2024
From Benzinga
What's Going On With Snowflake Stock Monday?
August 12, 2024
From Benzinga
What's Going On With Applied Materials Stock?
August 12, 2024
From Benzinga
Why Greenlane Holdings Stock Is Soaring
August 12, 2024
From Benzinga
Robinhood Analysts See 'Attractive Entry Point' For Investors Following Q2 Earnings: 'We Forecast A Continued Acceleration'
August 12, 2024
From Benzinga
Ascendis' Hypoparathyroidism Drug Scores FDA Approval As First and Only Treatment, Replacing Takeda's Drug Discontinued Due To Supply Issues
August 12, 2024
From Benzinga
Starbucks Stock Is Heating Up Monday: What's Going On?
August 12, 2024
From Benzinga
From Benzinga
Delay Hits Humacyte's Bioengineered Human Tissue Implant For Vascular Trauma Injuries, FDA Extends Time To Review
August 12, 2024
From Benzinga
Heart Failure-Focused scPharmaceuticals Secures FDA Approval For Expanded Use Of Furoscix, Receives Funding To Expand Commercialization
August 12, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.